Literature DB >> 26092646

Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model.

Marius Roman1, Olivera Gjorgjimajkoska2, Desley Neil3, Sukumaran Nair4, Simon Colah4, Jasvir Parmar4, Steven Tsui4.   

Abstract

BACKGROUND: Ex vivo lung perfusion with acellular solutions is an established technique for assessing marginal donor lungs. We evaluated the utility of a blood-based lung preservation fluid as an alternative perfusate.
METHODS: Donor lungs from 50-kg donation after cardiac death pigs (n = 24) were randomized into 3 groups: acellular, commercial blood-based, and Papworth-Blood. Physiologic function was evaluated using conventional markers of pulmonary vascular resistance, pulmonary compliance, lactate excretion, partial pressure of oxygen/fraction of inspired oxygen, and wet-to-dry ratios. The immunologic profile was assessed by fluorescence-activated cell sorting analysis of bronchoalveolar lavage and cells entrapped in the leucocyte filter. Cytokines were quantified using a commercial platform.
RESULTS: No significant difference was noted in pulmonary vascular resistance (p = 0.26), compliance (p = 0.12), partial pressure of oxygen/fraction of inspired oxygen (p = 0.06) and wet-to-dry ratios (p = 0.26) between groups. There was no difference between the percentages of lymphocytes (p = 0.51), macrophages (p = 0.87), monocytes (p = 0.68), and dendritic cells (p = 0.65) in the leukocyte filters. Interleukin (IL)-1β (p = 0.36), IL-6 (p = 0.08), IL-8 (p = 0.64), and IL-18 (p = 0.14) were elevated in all groups. In bronchoalveolar lavage, IL-8 was significantly higher in the acellular group (p = 0.04). Electron microscopy cell characteristics were similar among the groups.
CONCLUSIONS: This study demonstrated no significant difference in the physiologic, immunologic, or ultrastructural parameters between lungs perfused with cellular or acellular solutions. The Papworth-Blood solution is a potential alternative perfusate for ex vivo lung perfusion.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ex vivo lung perfusion; cellular immunology; electron microscopy; lung transplantation; organ perfusion; perfusates

Mesh:

Year:  2015        PMID: 26092646     DOI: 10.1016/j.healun.2015.03.023

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

1.  Methylene Blue Protects the Isolated Rat Lungs from Ischemia-Reperfusion Injury by Attenuating Mitochondrial Oxidative Damage.

Authors:  Wen-Fang Tian; Si Zeng; Qiong Sheng; Jun-Liang Chen; Ping Weng; Xiao-Tong Zhang; Jia-Jia Yuan; Qing-Feng Pang; Zhi-Qiang Wang
Journal:  Lung       Date:  2017-12-04       Impact factor: 2.584

Review 2.  Machine perfusion of thoracic organs.

Authors:  Dirk Van Raemdonck; Filip Rega; Steffen Rex; Arne Neyrinck
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.

Authors:  Roumen Parapanov; Xingyu Wang; Yabo Wang; Anne Debonneville; Jérôme Lugrin; Lucas Liaudet; Thorsten Krueger
Journal:  Transplant Direct       Date:  2022-06-10

Review 4.  The pig as a model for immunology research.

Authors:  Reinhard Pabst
Journal:  Cell Tissue Res       Date:  2020-04-30       Impact factor: 5.249

5.  Cellular and acellular ex vivo lung perfusion preserve functional lung ultrastructure in a large animal model: a stereological study.

Authors:  Jasmin Steinmeyer; Simon Becker; Murat Avsar; Jawad Salman; Klaus Höffler; Axel Haverich; Gregor Warnecke; Christian Mühlfeld; Matthias Ochs; Anke Schnapper-Isl
Journal:  Respir Res       Date:  2018-12-04

6.  Multiday maintenance of extracorporeal lungs using cross-circulation with conscious swine.

Authors:  Ahmed E Hozain; Yuliya Tipograf; Meghan R Pinezich; Katherine M Cunningham; Rachel Donocoff; Dawn Queen; Kenmond Fung; Charles C Marboe; Brandon A Guenthart; John D O'Neill; Gordana Vunjak-Novakovic; Matthew Bacchetta
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-17       Impact factor: 6.439

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.